Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study.
Chang, Chun-Hung
Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. [electronic resource] - Journal of affective disorders Aug 2015 - 44-9 p. digital
Publication Type: Journal Article
1573-2517
10.1016/j.jad.2015.04.027 doi
Adult
Anastrozole
Androstadienes--therapeutic use
Antineoplastic Agents--therapeutic use
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--epidemiology
Chemotherapy, Adjuvant
Depressive Disorder--epidemiology
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Letrozole
Middle Aged
Nitriles--therapeutic use
Population Surveillance--methods
Proportional Hazards Models
Retrospective Studies
Risk
Taiwan--epidemiology
Tamoxifen--therapeutic use
Trastuzumab--therapeutic use
Triazoles--therapeutic use
Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. [electronic resource] - Journal of affective disorders Aug 2015 - 44-9 p. digital
Publication Type: Journal Article
1573-2517
10.1016/j.jad.2015.04.027 doi
Adult
Anastrozole
Androstadienes--therapeutic use
Antineoplastic Agents--therapeutic use
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--epidemiology
Chemotherapy, Adjuvant
Depressive Disorder--epidemiology
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Letrozole
Middle Aged
Nitriles--therapeutic use
Population Surveillance--methods
Proportional Hazards Models
Retrospective Studies
Risk
Taiwan--epidemiology
Tamoxifen--therapeutic use
Trastuzumab--therapeutic use
Triazoles--therapeutic use